PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare
NCT ID: NCT07209722
Last Updated: 2026-01-26
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1377 participants
OBSERVATIONAL
2023-09-22
2025-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-component Intervention to Train Providers to Promote PrEP for Girls and Women in the Deep South
NCT06487390
A Women-Focused PrEP Intervention
NCT03699722
Identification of the Pre-exposure Prophylaxis (PrEP) Cascade for Women.
NCT03705663
Integrating PrEP Into Family Planning Services at Title X Clinics in the Southeastern US
NCT04097834
Implementing PrEP for Women Who Inject Drugs
NCT05360849
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sexual Health-PRO
Patients seen during routine GYN clinic visit.
PrEP acronym (pre-exposure prophylaxis)
Tracked PrEP prescriptions over 8 months among patients who completed the survey
Post visit (fidelity) survey
Patients who completed the survey outside of clinic visit
PrEP acronym (pre-exposure prophylaxis)
Tracked PrEP prescriptions over 8 months among patients who completed the survey
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PrEP acronym (pre-exposure prophylaxis)
Tracked PrEP prescriptions over 8 months among patients who completed the survey
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael J Mugavero, MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Mugavero, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-300008345
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.